1. Why Biosimilars are Malaysia’s next health investment  NST Online
  2. EU Clears Path for Biosimilars in Diabetes & Bone Health  Medscape
  3. CHMP Positive Opinions for Denosumab & Insulin Glargine Biosims  Pearce IP
  4. EMA recommends approval for nine biosimilars  Generics and Biosimilars Initiative
  5. Biosimilars: a vital remedy for Europe’s healthcare challenges  Labiotech.eu